Fielmann Group AG's EBIT per Share for the
three
months ended in Mar. 2026 was CHF0.91.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was CHF3.51.
During the past 12 months, the average EBIT per Share Growth Rate of Fielmann Group AG was 16.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 21.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 7.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 4.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Fielmann Group AG's EBIT per Share or its related term are showing as below:
XSWX:FIE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.8 Med: 3.7 Max: 21.1
Current: 21.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Fielmann Group AG was 21.10% per year. The lowest was -45.80% per year. And the median was 3.70% per year.
XSWX:FIE's 3-Year EBIT Growth Rate is ranked better than 66.38% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.65
vs XSWX:FIE: 21.10
Fielmann Group AG (XSWX:FIE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Fielmann Group AG EBIT per Share Related Terms
Fielmann Group AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (XSWX:FIE) has a EBIT per Share of CHF3.51 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Fielmann Group AG and its competitors. According to the industry distribution chart, Fielmann Group AG ranks #232 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 33.6%.
Is Fielmann Group AG's EBIT per Share too high?
Fielmann Group AG's current EBIT per Share is CHF3.51. Based on the distribution chart, Fielmann Group AG ranks #232 out of 690 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #232 out of 690 companies for EBIT per Share. This puts Fielmann Group AG in the upper half of its industry. The industry median EBIT per Share is 9.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.65, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current EBIT per Share is CHF3.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current EBIT per Share of CHF3.51. The stock's GF Value™ is CHF49.51, compared to a current price of CHF40.45 — trading 18.3% below its estimated fair value. The current EBIT per Share is CHF3.51. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current EBIT per Share is CHF3.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF40.45 is trading 18.3% below its estimated GF Value™ of CHF49.51.
Key valuation signals for XSWX:FIE:
EBIT per Share: CHF3.51
GF Value™: CHF49.51 vs. price of CHF40.45 (18.3% below fair value)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score
Get the complete analysis for XSWX:FIE
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
